Call  +41 61 926 6040
Fax +41 61 926 6049
Toggle Nav
My Cart
Search
Advanced Search
Account
Settings

Inflammation

Toggle Nav

Items 31-36 of 36

Page
per page
Set Descending Direction
  1. Progranulin (human) ELISA Kit (mAb/mAb)
    AG-45B-0027
    AG-45B-0027-KI0196 wells
    CHF 610.00
    Manual
    Add to Compare
    Learn More
    Progranulin (human) ELISA Kit (mAb/mAb)
  2. Sortilin (human) (rec.) (His)
    AG-40B-0229
    AG-40B-0229-C05050 µg
    CHF 440.00
    Add to Compare
    Learn More
    Sortilin (human) (rec.) (His)
  3. SUMO1 (human) (rec.) (Rhodamine 110)
    SBB-PS0028
    SBB-PS0028-C05050 µg
    CHF 434.00
    Add to Compare
    Learn More
    Signal to Background: The signal to background ratio was determined by 100% hydrolysis of 200nM, 100nM, 50nM SUMO1-Rhodamine 110 to liberate the quenched conjugate. Assay Buffer: 50mM HEPES pH 7.5, 1mM TCEP, 0.1mg/ml BSA.
  4. SUMO2 (human) (rec.) (Rhodamine 110)
    SBB-PS0029
    SBB-PS0029-C05050 µg
    CHF 434.00
    Add to Compare
    Learn More
    Signal to Background: The signal to background ratio was determined by 100% hydrolysis of 200nM, 100nM, 50nM SUMO2-Rhodamine 110 to liberate the quenched conjugate. Assay Buffer: 50mM HEPES pH 7.5, 1mM TCEP, 0.1mg/ml BSA.
  5. UcH-L3 (human) (rec.) (untagged)
    SBB-DE0023
    SBB-DE0023-C05050 µg
    CHF 278.00
    Add to Compare
    Learn More
    Michaelis–Menten Kinetics: Ubiquitin Rhodamine 110 serially diluted from 1.6 to 0.05µM was digested with 30pM UcHL3 over time. The assay was carried out in a reaction buffer of 50mM HEPES pH 7.5, 100mM NaCl, 1mM TCEP, 0.1mg/ml BSA, at 25°C. Initial
  6. VIP (human, mouse, rat) . acetate [RLF-100]
    CAS  1444827-29-5 | 40077-57-4 (free base)
    AG-CP3-0041
    AG-CP3-0041-M0011 mg
    CHF 90.00
    AG-CP3-0041-M0055 mg
    CHF 210.00
    AG-CP3-0041-M02525 mg
    CHF 430.00
    Add to Compare
    Learn More
    VIP (human, mouse, rat) . acetate [RLF-100]

Items 31-36 of 36

Page
per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.